Discontinuation report CEFZIL TABLETS - 250MG

Last updated on 2017-07-01 History
Report ID 3068
Drug Identification Number 02163659
Brand name CEFZIL TABLETS - 250MG
Common or Proper name Cefprozil
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFPROZIL
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 BTL x 100
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2017-06-30
Remaining supply date 2017-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-07-01 English Compare
v5 2017-04-03 French Compare
v4 2017-04-03 English Compare
v3 2017-03-16 French Compare
v2 2017-03-16 English Compare
v1 2017-03-16 English Compare